Đặc điểm dịch tễ học sa sút trí tuệ ở người cao tuổi tại hai quận, huyện Hà Nội

125. Jicha GA, Dickson DW, Parisi JE, et al (2006), "Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia", Arch Neurol, 63, pp. 674-681.

126. Jick H, Seshadri S. Zornberg GL, et al (2000), "Statins and the risk of dementia", Lancet, 356, pp. 1627-1631.

127. Jorm AF, Jolley D (2008), "The incidence of dementia: a meta-analysis",

Neurology, 51, pp. 728-33.

128. Karp A, Wang HX, Paillard-Borg S, et al (2006), "Mental, physical and social components in leisure activities equally contribute to decrease dementia risk", Dement Geriatr Cogn Disord, 21, pp. 65-73.

129. Katzman R (1976), "The prevalence and malignancy of Alzheimer disease: a major killer (editorial)", Arch Neurol, 33, pp. 217-218.

130. Kempermann G, Gage FH, Kuhn HG (1997), "More hippocampal neurons in adult mice living in an enriched environment", Nature, 386, pp. 493–495.

131. Keskinoglu P, Picakciefe M, Giray H, Bilgic N, Ucku R (2005), "The prevalence and risk factors of dementia in the elderly population in low socio economic region of Izmir", Turkey, Arch Gerontol Genatr, (4), pp. 353-360.

132. Khachaturian AS, Corcoran C, Mayer LS, et al (2004), "Apolipoprotein E 4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache County Study", Arch Gen Psychiatry, 61(5), pp. 518-524.

Có thể bạn quan tâm!

Xem toàn bộ 138 trang tài liệu này.

133. KillianyRJ, Moss M, Gomez-isla T, et al (2000), "Use of structural MRI to predict who will get AD", Ann Neurol, 47, pp. 430-439.

134. Knoefel JE, et al (2006), "Can our leisure activities help to prevent cognitive decline", Neurology, 22, pp. 21-22.

135. Kogure D, Ohnishi, T Matsuda H, et al (2000), "Longitudinal evaluation of early AD using brain perfusion SPECT", N'ucl Med, 4 (1), pp. 1155- 1162.

136. Kondo K, Shido K, Niino M (1994), "A case-control study of Alzheimer’s disease in Japan significance of life-styles", Dementia, 5 (6), pp. 314-326.

137. Kumar R, Christensen, H Dear KB, et al (2004), "Prevalence of MCI in 60 to 64 years old community dwelling individuals", Dement Geriatr Cogn Disord, 19 (2-3), pp. 67-74.

138. Ngandu T, Laitinen MH, Rovio S, et al (2006), "Fat intake at midlife and risk of dementia and Alzheimer’s disease: a population-based study", Dement Geriatr Cogn Disord, 22 (1), pp. 99-107.

139. Larson EB, Bowen JD, Wang L, et al (2006), "Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older", Ann Intern Med, 144, pp. 73-81.

140. Launer LJ, Ott A, Jama JW, et al (1997), "Histamine H2 blocking drugs and the risk of Alzheimer’s disease: the Rotterdam Study", Neurobiol Aging, 18, pp. 257–159.

141. Laura Fratiglioni, von Strauss E, Winblad B (2007), "Prevention of Alzheimer's disease and dementia", Major findings from the Kungsholmen Project, Karolinska Institutet, Aging Research Center, Division of Geriatric Epidemiology, NVS, and Stockholm Gerontology Research Center, Gävlegatan 16, S-113 30 Stockholm, Sweden, Physiology & Behavior, 92 (1-2), pp.98-104.

142. Lazarov O, Tang YP Robinson J, et al (2005), "Environmental enrichment reduces A levels and amyloid deposition in transgenic mice", Cell, 120, pp. 701-713.

143. Lee T.S, Hong J.H, Cho M.C (2007), "Biomedical digital assitant for ubiquitous healthcare", Conf. Proc. IEEE Eng. Med. Biol.Soc., 1, pp. 1790-1793.

144. Letenneur L (2004), "Risk of dementia and alcohol and wine consumption: a review of recent results", Biol Res, 37, pp. 189-193.

145. Letenneur L (2007), "Moderate alcohol consumption and risk of developing dementia in the elderly: the contribution of prospective studies", Ann Epidemiol, 17, pp. 43–45.

146. Li G, Kukull WA, Higdon R, et al (2004), "Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study", Neurology, 63, pp. 1624–1628.

147. Li G, Sonnen JA, Larson EB, et al (2007), "Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease", Neurology, 69, pp. 878-885.

148. Lim G, Chu T, Yang F, et al (2001), "Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice", Neurobiol Aging, 22, pp. 983-991.

149. Luchsinger JA, Shea S, Tang MX, et al (2003), "Antioxidant vitamin intake and risk of Alzheimer disease", Arch Neurol, 60, pp. 203-208.

150. Luchsinger JA, Honig LS, Reitz C, et al (2005), "Aggregation of vascular risk factors and risk of incident Alzheimer disease", Neurology, 65, pp. 545-551.

151. Luchsinger JA, Patel B, Reitz C, et al (2007), "Relation of diabetes to mild cognitive impairment", Arch Neurol, 64, pp. 570-575.

152. Masaki KH, Izmirlian G, Losonczy KG, et al (2000), "Association of vitamin E and C supplement use with cognitive function and dementia in elderly men", Neurology, 54, pp. 1265-1272.

153. McGeer PL, Itagaki S, Akiyama H, et al (1989), "Activation of the classical complement pathway in brain tissue of Alzheimer patients", Neurosci Lett, 107, pp. 341-346.

154. McGeer PL, Rogers J, McGeer E, et al (1990), "Anti-inflammatory drugs and Alzheimer disease", Lancet, 335, pp. 1037.

155. McGuinness B, Passmore P, Todd S, et al (2006), "The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease", Cochrane Database of Systematic Reviews, Article No:CD004034

156. McKhann G, Folstein M, Drachman D, et al (1984), "Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task force on Alzheimer’s disease", Neurology, 34, pp. 939–944.

157. McMahon JA, Skeaff CM, Green TJ, et al (2006), "A controlled trial of homocysteine lowering and cognitive performance", N Engl J Med, 354, pp. 2764–2772.

158. Mintun MA, Sheline YI, Larossa GN, et al (2006), "PIB in a nondemented population: potential antecedent marker of Alzheimerdisease", Neurology, 67, pp. 446-452.

159. Moore TL, Rosene DL, Killiany RJ, et al (2003), "Hypertension-induced changes in monoamine receptors in the prefrontal cortex of rhesus monkeys", Neuroscience letter, 120, pp. 177-189.

160. Moroney JT, Berglund L, Tang M-X, et al (1999), "Low-density lipoprotein cholesterol and the risk of dementia with stroke", JAMA, 282, pp. 254-260.

161. Morris MC, Scherr PA, Beckett LA, et al (1998), "Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease", Alzheimer Dis Assoc Disord, 12, pp. 121-126.

162. Morris MC, Bienias JL, Evans DA, et al (2003), "Dietary fats and the risk of incident Alzheimer disease", Arch Neurol, 60, pp. 1072.

163. Morris MC, Bienias JL Evans DA, et al (2003), "Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease", Arch Neurol, 60, pp. 940–946.

164. Morris MC, Tangney CC, Evans DA, et al (2005), "Fish consumption and cognitive decline with age in a large community study", Arch Neurol, 62, pp. 1849-1853.

165. Morris MC, Tangney CC, Evans DA, et al (2006), "Dietary copper and high saturated and trans fat intakes associated with cognitive decline", Arch Neurol, 63, pp. 1085-1088.

166. Morrison JH, Schmidt PJ, Brinton RD, et al (2006), "Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women", J Neurosci, 26, 10332-10348.

167. MRC/BHF Heart Protection Study (2002), "MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial", Lancet, 360, pp. 23-33.

168. National Institutes of Health (1997), "The sixth report of Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure", NIH publication, 98, pp. 11- 13.

169. Nolan KA, Seligmann AW, Lino MM, et al (1998), "Absence of vascular dementia in an autopsy series from a dementia clinic", J Am Geriatr Soc, 46, pp. 597-604.

170. Notkola IL, Pekkanen J, Sulkava R, et al (1998), "Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer’s disease", Neuroepidemiology, 17, pp. 14-20.

171. Oslin D, Smith DM, Atkinson RM, Hendrie H (1998), "Alcohol related dementia: proposed clinical criteria", Int J Geriatr Psychiatry, 13 (4), pp. 202-212.

172. Otto A, van Harskamp F, Stolk RP, Pols HA, Hofman A, Breteler MM (1999), "Diabetes mellitus and the risk of dementia: the Rotterdam Study", Neurology, 54 (6), pp. 1137-1143.

173. Otto A, van Harskamp F, Stolk RP, et al (2000), "Diabetes mellitus and the risk of dementia: the Rotterdam Study", Neurology, 53, pp. 1937- 1942.

174. Pahan K, Namboodiri AMS, Sheikh FG, et al (1997), "Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages", J Clin Invest, 100, pp. 2671–2679.

175. Peila R, Masaki K, White LR, et al (2006), "Reducing the risk of dementia: efficacy of long-term treatment of hypertension", Stroke, 37, pp. 1165-1170.

176. Petersen R, Waring SC, Smith G, et al (1999), "Mild cognitive impairment: clinical characterization and outcome", Arch Neurol, 56, pp. 303-308.

177. Petersen RC, Ganguh Stevens JC , et al (2001), "Practice parameters: early detection of dementia, MCI (an evidence - based review)", Report

of the quality standards sub committee of the American Academy of Neurology, Neurology, 56, pp. 1133-1142.

178. Petersen R (2005), "Vitamin E and donepezil for the treatment of mild cognitive impairment", N Engl J Med, 352, pp. 2379-2388.

179. Pham TM, Albeck D, Ickes B, et al (1999), "Changes in brain nerve growth factor levels and nerve growth factor receptors in rats exposed to environmental enrichment for one year", Neuroscience, 94, pp. 279- 286.

180. Piguet O, Creasey H, Grayson DA, et al (2003), "Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study", Neuroepidemiology, 22, pp. 165-171.

181. Plassman BL, Helms M, Welsh KA, et al (1995), "Intelligence and education as predictors of cognitive state in late life: a 50 year follow- up", Neurology, 45, pp. 1446-1450.

182. Prencipe M, Ferretti C, Casini AR, Lattanzio MT, Fiorelli M, Culasso F (1996), "Prevalence of dementia in an elderly rural population: effects of age, sex, and education", J Neurol Neurosurg Psychiatry, 60 (6), pp: 628-33.

183. Prince M, Bird A, Lewis G, et al (1996), "A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population", Psychol Med, 26, pp. 555-568.

184. Qiu CJ, Zhang W, Tang MN, et al (2003), "The prevalence of MCI among resident aged 55 or over in Chengdu area, Zhonghua Liu Xing Bing Xue Za Zhi", 24 (12), pp. 1104-1107.

185. Qiu C, Marengoni A. Winblad B, et al (2006), "Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study", Arch Intern Med, 166, pp. 1003-1008.

186. Quinn J, Moore MM, Montine K, et al (2004), "Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer’s disease", Alzheimers Dis, 6, pp. 93-97.

187. Quiu, et al (2007), "The epidemiology of dementia, an update, Currrent opinion in psychiatry", 20, pp. 380-385.

188. Rapp SR, Shumaker SA, Espeland MA, et al (2003), "Effect of estrogen plus progestin on global cognitive function in postmenopausal women. The Women’s Health Initiative Memory Study: a randomized controlled trial", JAMA, 289, pp. 2663-2672.

189. Refolo LM, Malester B, Pappolla MA, et al (2000), "Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model", Neurobiol Dis, 7, pp. 321-331.

190. Reines SA, Morris JC, Block GA, et al (2004), "Rofecoxib: no effect on Alzheimer’s disease in a 1-year, randomized, blinded, controlled study", Neurology, 62, pp. 66-71.

191. Riemenschneider M, Wagenpfeil Lautenschlager - N (2002), "CSF. tau and amyloid 42 proteins identify AD in subjects with MCI", PNeurol, 59, pp. l729-1734.

192. Rockwood K, Hogan DB, Kirkland S, et al (2002), "Use of lipid- lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people", Arch Neurol, 59, pp. 223-227.

193. Rodriguez EG, Birzescu MA, Dodge HH, et al (2002), "Use of lipid- lowering drugs in older adults with and without dementia: a community-based epidemiological study", J Am Geriatr Soc, 50, pp. 1852-1856.

194. Rogers J, Hempelman SR, Kirby LC, et al (1993), "Clinical trial of indomethacin in Alzheimer’s disease", Neurology, 43, pp. 1609-1611.

195. Roster N, vichart I, Jellinger KA (2001), "Clinical significance of neurobiochemical profiles in the lumbar CSF of AD patients", I Neural Transit, l08, pp. 231-246.

196. Rovio S, Kareholt I, Helkala EL, et al (2005), "Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease", Lancet Neurol, 4, pp. 705-711.

197. Saczynski JS, Pfeifer LA, Masaki K, et al (2006), "The effect of social engagement on incident dementia: the Honolulu-Asia Aging Study", Am J Epidemiol, 163, pp. 333-340.

198. Sahlin C, Pettersson FE, Nilsson LN, et al (2007), "Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced A levels in cellular models of Alzheimer’s disease", Eur J Neurosci, 26, pp. 882-889.

199. Sano M, Ernesto C, Thomas RG, et al (1997), "A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease: the Alzheimer’s Disease Cooperative Study", N Engl J Med, 336, pp. 1216-1222.

200. Santanello NC, Barber BL, Applegate WB, et al (1997), "Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) pilot study", J Am Geriatr Soc, 45, pp. 8-14.

201. Scarmeas N, Stern Y (2004), "Cognitive reserve: implications for diagnosis and prevention of Alzheimer’s disease", Curr Neurol Neurosci Rep, 4, pp. 374-380.

202. Scarmeas N, Stern Y, Tang MX, et al (2006), "Mediterranean diet and risk for Alzheimer’s disease", Ann Neurol, 59, pp. 912-921.

203. Scarmeas N, Stern Y, Mayeux R, et al (2006), "Mediterranean diet, Alzheimer disease, and vascular mediation", Arch Neurol, 63, pp. 1709-1717.

204. Seshadri S, Zornberg GL, Derby LE, et al (2001), "Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease", Arch Neurol, 58, pp. 435-440.

205. Shepherd J, Blauw GJ, Murphy MB, et al (2002), "Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial", Lancet, 360, pp. 1623-1630.

206. Signoret JL, Benoit N (1991), "Examination and memory", Rev, Prat, 41 (10), pp. 866-868.

207. Small GW, Mazziotta JC, Collins MT, et al (1995), "Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer’s disease", JAMA, 273, pp. 942-947.

208. Soininen H, West C, Robbins J, et al (2007), "Long-term efficacy and safety of celecoxib in Alzheimer’s disease", Dement Geriatr Cogn Disord, 23, pp. 8-21.

209. Solomon SD, McMurray JJV, Pfeffer MA, et al (2005), "Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention", N Engl J Med, 352, pp. 1071-1080.

210. Sonnen JA, Larson EB, Crane PK, et al (2007), "Pathological correlates of dementia in a longitudinal, population-based sample of aging", Ann Neurol, 62, pp. 406-413.

211. Stessman J., Hammerman R., Cohen. (1997), "Home hospitalization in the spectrum of community geriatric care: Hadasah University Hospital", Muont Seonpus Jerusalem, Israel, Disabil, Rchabit., pp. 32- 37.

212. Suh G-H, Kim J.K, Cho M.J (2003), Community study of dementia in the Korean rural population, 37 (5), pp. 606-12.

213. Szekely C, Thorne J, Zandi P, et al (2004), "Nonsteroidal anti- inflammatory drugs for the prevention of Alzheimer’s disease: a systematic review", Neuroepidemiology, 24, pp. 159-169.

214. Szekely CA, Green RC, Breitner JC, et al (2008), "No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies", Neurology, 70, pp. 2291-2298.

215. Tervos, Kivipelto M, Hannien T, et al (2004), "Incidence and risk factors for MCI: a population based three - year follow - up study of cognitively impairment elderly subjects", Dement Geriatr Cogn Disord, 17 (3), pp. 196-203.

216. Tierney MC, Szalai JP, Snow G, et al (1996), "The prediction of Alzheimer disease: the role of patient and informant perceptions of cognitive deficits", Arch Neurol, 53, pp. 423-427.

217. Van Praag H, Kempermann G, Gage FH (2000), "Neural consequences of environmental enrichment", Nat Rev Neurosci, 1, pp. 191-198.

218. Van Praag H, Shubert T, Zhao C, et al (2005), "Exercise enhances learning and hippocampal neurogenesis in aged mice", J Neurosci 25, pp. 8680-8685.

219. Vermeer SE, Prins ND, Den Heijer T, et al (2003), "Silent brain infarcts and the risk of dementia and cognitive decline", N Engl J Med, 348, pp. 1215-1222.

220. Wang W, Wu S, Cheng X, Dai H, Ross K, Du X, Yin W (2000), "Prevalence of Alzheimer's disease and other dementing disorders in an urban community of Beijing, China", Neuroepidemiology, 19 (4), pp:194-200.

221. Whitehead D. (2004), "The European Health Promoting Hospitals (HPH) project: how far on?", Health Promot.Int., 19 (2), pp. 259-267.

222. Whitmer RA, Sidney S, Selby J, et al (2005), "Midlife cardiovascular risk factors and risk of dementia in late life", Neurology, 64, pp. 277– 281.

223. Willis SL, Tennstedt SL, Marsiske M, et al (2006), "Long-term effects of cognitive training on everyday functional outcomes in older adults", JAMA, 296, pp. 2805-2814.

224. Wilson RS, Bennett DA, Mendes de Leon CF, et al (2005), "Distress proneness and cognitive decline in a population of older persons", Psychoneuroendocrinology, 30, pp. 11-17.

225. Wilson RS, Schneider JA, Boyle PA, et al (2007), "Chronic distress and incidence of mild cognitive impairment", Neurology, 68, pp. 2085- 2092.

226. Wilson RS, Krueger KR, Arnold SE, et al (2007), "Loneliness and risk of Alzheimer disease", Arch Gen Psychiatry, 64, pp. 234-240.

227. Wilson RS, Arnold SE, Schneider JA, et al (2007), "Chronic distress, age related neuropathology, and late-life dementia", Psychosom Med 69, pp. 47-53.

228. Winblad B, Jonsson L, Wimo A (2005), "The worldwide costs of dementia, presented at the Alzheimer’s Association International Conference on Prevention of Dementia", Washington, DC,

229. Wolf H, Ecke GM, Bettin S, et al (2000), "Do white matter changes contribute to the subsequent development of dementia in patients with MCI? A longitudinal study", Int J Genat Psychiatry, 15, pp. 803-812.